Replies to post #279279 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I agree when Doc328 says approval for aducanumab is good for setting the price for A2-73 if approved and better that Biogen's vial, or is it vile?

[Doc328]

Biogen already has their sales reps, managers, medical science liaisons, infusion experts, reimbursement people, etc hired in order to launch within days of the expected approval in March. Approval will be great for BIIB and good for AVXL. A273 is still minimum of 4 years away for AD so this is also a positive for mild AD patients. If A273 works better, it will eventually outperform Aduca in the marketplace just like the oral MS agents are now used more than the older injectable medications.

Nov 6 will be an interesting day. BIIB will get discussed much more but AVXL gets to present on a big Alzheimer day, so will have a chance to shine

[mrplmer]

Zig Day late but we're going to $6 today.

[Phoenix64]

Agree. This is meant for BIIB. Once again our good news will be completely overshadowed.